SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 143 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,840,000 | +69.2% | 1,800 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $9,360,000 | +136.1% | 1,800 | +38.5% | 0.00% | +100.0% |
| Q4 2016 | $3,965,000 | -34.1% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,019,000 | -20.0% | 1,300 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $7,527,000 | -20.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $9,412,000 | +78333.3% | 1,300 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $12,000 | +33.3% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $9,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |